AgeneBio Competitors and Similar CompaniesClear all

Supernus Pharmaceuticals's competitors and similar companies include Shionogi and Alector.

	Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.	Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.	Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
Founding Date	Founding Date 2005	Founding Date 1878	Founding Date 2013
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development mental health pharma	Tags Healthcare biotech drug development mental health pharma	Tags Healthcare biotech drug development mental health pharma
Locations	Locations Rockville, US HQ	Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more	Locations San Francisco, US HQ
Employees	Employees 6527% increase	Employees 4,955	Employees 2382% decrease
Valuation ($)	Valuation ($) 1.9 b	Valuation ($) 12.3 b	Valuation ($) 495.3 m
Financial
Revenue (est.)	Revenue (est.) $719m (FY, 2025)	Revenue (est.) ¥499.7b (FY, 2026)	Revenue (est.) $21m (FY, 2025)
Cost of goods	Cost of goods $74.6m (FY, 2025)	Cost of goods ¥55.5b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit $644.4m (FY, 2025)	Gross profit ¥491.3b (FY, 2026)	Gross profit N/A
Net income	Net income ($38.6m) (FY, 2025)	Net income ¥205.9b (FY, 2026)	Net income ($142.9m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 69.5m	Total funding raised $ 4.7m	Total funding raised $ 194.5m